Chat with us, powered by LiveChat


Glycomics Market Report


Glycomics Market, by Product (Enzymes, Kits, Reagents, and Instruments), Applications (Drug Discovery & Development, Diagnostics, and Others), End-Users (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and CROs), Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027


Pages: 130

Apr 2020

The global glycomics market is expected to grow to contribute to rising research and development activities in biotechnology. Research on glycans is crucial for biological functions to accurately analyze and develop modern tools to study glycomics in depth. 

Glycomics Market, Analysis:

Glycomics is the scientific knowledge of the structure, function, and biology of carbohydrates, also called glycans. Carbohydrates are an essential element of all living cells and therefore play a major role in multiple fields of health care, biochemical, and biotechnological studies. Growing innovation in research &development in the pharmaceutical and biotechnology industries, along with expansion in the proteomics industry, is expected to fuel the market growth in the future. 

Growth in research & development is expected to drive the global glycomics market:

The growing drug discovery process is resulting in research institutes to invest their resources in R&D activities. This rapid development in research is contributing towards establishment of new glycomics technology. Moreover, government initiatives to increase funding for the R&D activities have contributed towards the overall growth and development in the global glycomics market. 

The high cost of tools is anticipated to restrain the growth of global glycomics market:

The glycomics procedure can be technically too difficult or very expensive for some end-users to use. Glycomics research includes heavy utilization of relatively costly instruments. In addition, glycomics is a complex subject, as carbohydrates are highly diverse in structure and often chained in branches. These factors are anticipated to bring a decline in the global glycomics market.

Technological innovations are anticipated to create enormous opportunities for the global glycomics market:

Technological advancement in the equipment and techniques of mass spectroscopy in glycomics has been used efficiently in modern times. Some of the modern techniques used in glycomics are electron capture and electron transfer dissociation fragmentation methods.  It assists in determining the refined molecular structure which obtains in a concurrent and at a massive scale. Moreover, there has been a recent development in the chromatographic isolation and separation of complex glycans.  Enhanced and innovative technologies in the glycomics field of study are estimated to create a wide scope of opportunities in the global glycomics market.  

Glycomics Market, by Product:

Enzymes will be most lucrative till 2027

By product, the global glycomics market is divided into enzymes, kits, reagents, and instruments. Enzymes are further distinguished into glycosyltransferases, neuraminidases, sialyl transferases, and glycosidases. Enzymes lead the market share as it is widely used in different recovery drug procedures.   

Glycomics Market, by Applications:

Drug discovery & development is estimated to dominate the market in the upcoming period

By applications, the global glycomics market is classified into drug discovery & development, diagnostics, and others. Out of these, drug discovery & development dominates the market share and is expected to continue till 2027. This growth is due to an increase in R&D activities for discovering new drugs and therapies to erase the gap of unmet needs in the biotechnology industry.

Glycomics Market, by End-Users:

Academic & research institutes are estimated to be the highest growing till 2027

By end-users, the global glycomics market is bifurcated into academic & research institutes, pharmaceutical & biotechnology companies, and CROs. Amongst these, the academic & research institutes dominate the market shares and are expected to continue its dominance in the forecasted period. The dominance is due to the expansion in the field of glycomics research supported by public and private organizations. The expansion is also facilitated by partnerships or collaborations between large organizations and academic institutes.

Glycomics Market, by Region:

Asia-Pacific region will have lucrative opportunities for the market investors

The global glycomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominates the market share due to the presence of a large number of pharmaceutical companies and huge investments in R&D activities. Asia-Pacific is anticipated to be the fastest-growing region due to expanding the healthcare sector, growing rate of patients, and inexpensive clinical trials. 

To explore more about Global Glycomics Market, get in touch with our analysts here.

Key Participants in the Global Glycomics Market:

Merger & acquisition and advanced product development are the frequent strategies followed by the market players

Key Participants in the Global Glycomics Market


Some of the major key players in the global glycomics market are The Merck Group, Agilent Technologies Inc., Thermo Fisher Scientific, New England Biolabs, Shimadzu Co., Takara Holdings, Sumitomo Bakelite Co. Ltd., Waters Co., AspariaGlycomics S.L., Bio-Techne Co. and others. 

To extend into local markets market players favor inorganic growth strategies. The global market players of glycomics focus more on merger & acquisition and advanced product growth. These are the often specific approaches adopted by existing companies. To concentrate more on market players' competition research, the study discusses the Poter’s five-forces model. 



  Historical Market Estimations


  Base Year for Market Estimation


  Forecast timeline for Market Projection


  Geographical Scope

  North America, Europe, Asia-Pacific, LAMEA

  Segmentation by Products

  • Enzymes
  • Kits
  • Reagents
  • Instruments

  Segmentation by Applications

  • Drug Discovery & Development
  • Diagnostics
  • Others

  Segmentation by End-Users

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology
  • Companies
  • CROs

  Key Countries Covered

U.S., Canada, Germany, France, Spain,

Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

  Key Companies Profiled

  • The Merck Group
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific
  • New England Biolabs
  • Shimadzu Co.
  • Takara Holdings
  • Sumitomo Bakelite Co. Ltd.
  • Waters Co.
  • AspariaGlycomics S.L.
  • Bio-Techne Co.

Source: Research Dive Analysis

Frequently Asked Questions

A. The Merck Group, Agilent Technologies Inc., and Thermo Fisher Scientific are some of the key players in the global glycomics market.

A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.

A. Technological advancements, product development, along with joint ventures, are the key strategies opted by the operating companies in this market.

A. New England Biolabs, Shimadzu Co., and Takara Holdings are the companies investing more in R&D activities for developing new products and technologies.

Research Methodology

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed